PD-L1 as the Prognostic Immune Biomarker for Predicting the Relapse of Locally Advanced Cervical Adenocarcinoma and Adenosquamous Carcinoma Treated with Definitive Chemoradiation Therapy.

Subjects

Subjects :

*BIOMARKERS
*ADENOCARCINOMA
*CHEMORADIOTHERAPY

Details

Language :

English

ISSN :

03603016

Volume :

99

Database :

Academic Search Index

Journal :

International Journal of Radiation Oncology, Biology, Physics

Publication Type :

Academic Journal

Accession number :

124774013

Full Text :

https://doi.org/10.1016/j.ijrobp.2017.06.1318